Home
>
Assessments
>
Endoluminal Treatments for Gastroesophageal Reflux Disease (GERD) (including Stretta, EndoCinch, and Enteryx)
Endoluminal Treatments for Gastroesophageal Reflux Disease (GERD) (including Stretta, EndoCinch, and Enteryx)
| Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered. |
| Review Date: |
February 11, 2004 |
| Recommendation: |
This topic was reviewed by the California Technology Assessment Forum on February 11, 2004. It was determined that that Stretta, Bard EndoCinch and Enteryx for the treatment of GERD do not meet California Technology Assessment Forum technology assessment criteria. |
| Decision: |
Does Not Meet CTAF Criteria |
| Full Assessment: |
Download (PDF) |
|
|
© 2012 California Technology Assessment Forum. All rights reserved.
